Biotech Intelligence Platform
Turn Global Biotech Signals, Into Strategic Intelligence
Biotech Signals. Structured for Decisions.
INSILENS converts global biotech activity into decision-grade intelligence for investors, executives, and business development teams.
July 1, 2026
June 24, 2026
June 15, 2026
June 9, 2026
—
Deals & financings tracked
—
Total signals published
—
New signals this week
—
People following InSilens
Built for the people who move biotech forward
Different roles, different questions — INSILENS structures signals around how each team actually makes decisions.
Investors
Track financings, M&A activity, and emerging platforms early enough to act — not after the press release.
Executives
Monitor competitive movement across modalities and indications to inform pipeline and portfolio strategy.
Business Development
Surface partnership and licensing opportunities before they become competitive bidding wars.
Signals sourced & cross-referenced from
SEC EDGARClinicalTrials.govFDAEMACompany IRPitchBook
Get the week's most important biotech signals — every Monday.
A curated digest of the deals, approvals, and technology shifts that matter, structured for fast decision-making.
